Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Pediatr Crit Care Med. 2012 Jan;13(1):e33–e38. doi: 10.1097/PCC.0b013e31820ac08f

Table 2.

Coagulation profiles of ALF patients undergoing ICP monitor placement. Coagulation abnormalities were significantly improved after treatment with blood product replacement.

Median value on admission to PICU prior to correction (range) Median value after correction prior to ICP monitor placement (range) P value
Partial thromboplastin time 52 (30–160) 38 (29–53) P< 0.03
Prothrombin time 45(19–109) 11.6(7–23) P<0.04
INR* 3.2(1.5–4.6) 0.8 (0.7–1.9) P< 0.04
*

International normalized ratio